bullish

Giant Biogene

Giant Biogene IPO Trading - Demand Was Relatively Better but Still Weak

221 Views03 Nov 2022 09:50
Giant Biogene (GB) raised around US$70m by pricing its  HK IPO at the low-end. In this note we talk about the trading dynamics.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x